B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IL15

MOLECULAR TARGET

interleukin 15

UniProt: P40933NCBI Gene: 36001 compounds

IL15 (interleukin 15) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting IL15

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Cefazolin1.102

About IL15 as a Drug Target

IL15 (interleukin 15) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented IL15 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

IL15 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.